Rusty Robertson has generated more than $500 million for her clients in 20 years of running her own companies, RPR & Associates and The Robertson Schwartz Agency, and raised over $200 million through her philanthropic associations. With her proven expertise in marketing, sales, forecasting, literary representation, advertising, and public relations, clients continuously turn to Rusty to act as their internal marketing department, financial advisor, and executive officer.
As the agency for numerous Forbes 100 companies, Rusty’s successes have also garnered her personal attention of the media. Advertising Age Magazine honored her as one of the Top 100 Marketers. Success Magazine named Rusty one of the most successful entrepreneurial women in the United States. Success Magazine’s year-end issue featured Robertson and company as one of America’s Super 8 Companies. Rusty’s book, Walking Up A Mountain in High Heeled Shoes, garnered her a million dollar advance from Simon and Schuster.
She was chosen by Margaret Thatcher to lead the way in founding Thatcher’s Global Educational Foundation. Rusty was a founding member of the Susan G. Komen Breast Cancer Foundation and was instrumental in the development of the Race for the Cure.
Rusty also co-founded Stand Up to Cancer, which has raised over $100 million in less than a year with Rusty on board as an executive leader. She co-produced Stand Up To Cancer’s history-making televised event, an unprecedented collaboration uniting the major television networks, entertainment industry executives, celebrities, and prominent leaders in cancer research and patient advocacy. ABC, CBS, and NBC donated one hour of simultaneous commercial-free primetime on September 5th, 2008 for a nationally televised fundraising event featuring live performances by legendary recording artists and stars from film and television. Within 9 months of the televised event, SU2C granted $73.5mm to Dream Teams of scientists from institutions all over the world working on translational research for all types of cancer. Additionally, $10mm in Innovative Grants was awarded to promising young scientists who rarely get funded in translational research. SU2C gives more money to fewer scientists and demands clinical trials within two years, mandating that results go from the “bench” to the patient within three years. The next Stand Up to Cancer multi-network televised event will air on September 10, 2010 in 200 countries.
|
